125 related articles for article (PubMed ID: 35748067)
1. Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage.
Kawamura T; Ichikawa M; Hatogai J; Koyama Y; Tachibana M; Kuwahara M; Negishi K; Matsumoto M; Miyazaki M; Ochiai W
Biopharm Drug Dispos; 2022 Aug; 43(4):130-139. PubMed ID: 35748067
[TBL] [Abstract][Full Text] [Related]
2. Zonation of the drug-metabolizing enzyme cytochrome P450 3A in infant mice begins in pre-weaning period.
Kitaoka S; Hatogai J; Ochiai W; Sugiyama K
J Toxicol Sci; 2018; 43(3):223-227. PubMed ID: 29540656
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines.
Scheer N; Kapelyukh Y; Chatham L; Rode A; Buechel S; Wolf CR
Mol Pharmacol; 2012 Dec; 82(6):1022-9. PubMed ID: 22918969
[TBL] [Abstract][Full Text] [Related]
5. Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity.
Uno Y; Minami Y; Tsukiyama-Kohara K; Murayama N; Yamazaki H
Biochem Pharmacol; 2023 Dec; ():115990. PubMed ID: 38110158
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of six forms of cytochrome P450 2C (CYP2C) in pigs.
Uno Y; Morikuni S; Shiraishi M; Asano A; Kawaguchi H; Murayama N; Yamazaki H
Xenobiotica; 2022; 52(9-11):963-972. PubMed ID: 36373600
[TBL] [Abstract][Full Text] [Related]
7. Short communication: insulin alters hepatic progesterone catabolic enzymes cytochrome P450 2C and 3A in dairy cows.
Lemley CO; Butler ST; Butler WR; Wilson ME
J Dairy Sci; 2008 Feb; 91(2):641-5. PubMed ID: 18218751
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility.
Treluyer JM; Gueret G; Cheron G; Sonnier M; Cresteil T
Pharmacogenetics; 1997 Dec; 7(6):441-52. PubMed ID: 9429229
[TBL] [Abstract][Full Text] [Related]
9. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone.
Uno Y; Fujino H; Kito G; Kamataki T; Nagata R
Mol Pharmacol; 2006 Aug; 70(2):477-86. PubMed ID: 16648389
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
[TBL] [Abstract][Full Text] [Related]
11. Zonation of cytochrome P450 enzyme expression in rat liver. Isozyme-specific regulation by pituitary dependent hormones.
Oinonen T; Mode A; Lobie PE; Lindros KO
Biochem Pharmacol; 1996 May; 51(10):1379-87. PubMed ID: 8787555
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Tissue Distribution of the Mouse
Graves JP; Gruzdev A; Bradbury JA; DeGraff LM; Edin ML; Zeldin DC
Drug Metab Dispos; 2017 Jul; 45(7):807-816. PubMed ID: 28450579
[TBL] [Abstract][Full Text] [Related]
13. CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice.
Pang X; Tang C; Kong F; Chen M; Chen X
Curr Drug Metab; 2020; 21(13):1040-1051. PubMed ID: 33267758
[TBL] [Abstract][Full Text] [Related]
14. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
[TBL] [Abstract][Full Text] [Related]
15. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities.
Wang H; Zhao Y; Bradbury JA; Graves JP; Foley J; Blaisdell JA; Goldstein JA; Zeldin DC
Mol Pharmacol; 2004 May; 65(5):1148-58. PubMed ID: 15102943
[TBL] [Abstract][Full Text] [Related]
17. Expression of
Graves JP; Bradbury JA; Gruzdev A; Li H; Duval C; Lih FB; Edin ML; Zeldin DC
FASEB J; 2019 Dec; 33(12):14784-14797. PubMed ID: 31690125
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and function of CYP2C isoforms in human intestine and liver.
Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
[TBL] [Abstract][Full Text] [Related]
19. Changes in the gene expression and enzyme activity of hepatic cytochrome P450 in juvenile Sprague-Dawley rats.
Asaoka Y; Sakai H; Sasaki J; Goryo M; Yanai T; Masegi T; Okada K
J Vet Med Sci; 2010 Apr; 72(4):471-9. PubMed ID: 20032627
[TBL] [Abstract][Full Text] [Related]
20. Liver lobe and strain differences in the activity of murine cytochrome P450 enzymes.
Rudeck J; Bert B; Marx-Stoelting P; Schönfelder G; Vogl S
Toxicology; 2018 Jul; 404-405():76-85. PubMed ID: 29879457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
